Oncology
14 Sep 2025
MARIPOSA Data Reveal Extended Survival in EGFR Lung Cancer
Overall survival in the Asia cohort of the Phase III MARIPOSA study has been reported to favor amivantamab combined with lazertinib compared with osimertinib monotherapy in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC).
Neurology
14 Sep 2025
Parkinson’s Linked to Distinct Gut Microbiota Patterns
Alterations in the gut microbiota are evident not only in patients with Parkinson’s disease but also in individuals with isolated REM sleep behavior disorder, suggesting that microbial changes may precede clinical onset of Parkinson’s.
Respiratory
13 Sep 2025
Large-Scale Study Confirms Mycobacterial Risk in Transplants
Solid-organ transplant recipients face a markedly higher risk of developing nontuberculous mycobacterial disease compared with the general population, and this risk translates into greater long-term mortality, according to findings from a large population-based cohort study.
